GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION? ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Том 10. 2018. С. 75-80
MODERN PROBLEMS OF SURGICAL INFECTIONS OF THE SKIN AND SOFT TISSUES CAUSED BY MRSA, AND THE WAYS OF THEIR SOLUTION ArticleZyryanov S.K., Sychyov I.N.Хирург. 2018. С. 31-43
GCP INSPECTION BY ROSZDRAVNADZOR ArticleBelousov D.Yu., Zyryanov S.K., Kolbin A.S., Karpenko L.I., Rogov E.S.Качественная клиническая практика. 2018. С. 66-76
LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE ArticleZYRYANOV S.K., ZATOLOCHINA K.E., ASETSKAYA I.L.Antibiotiki i Khimioterapiya. Том 63. 2018. С. 46-51
IN VITRO EQUIVALENCE EVALUATION OF BETAHISTINE GENERIC MEDICINAL PRODUCTS AS A TOOL POTENTIALLY DETERMINING THE EFFICACY OF PHARMACOTHERAPY [OTSENKA ÉKVIVALENTNOSTI IN VITRO VOSPROIZVEDENNYKH PREPARATOV BETAGISTINA KAK INSTRUMENTA, POTENTSIAL'NO OPREDELIAIUSHCHEGO ÉFFEKTIVNOST' FARMAKOTERAPII] ArticleZyryanov S.K., Butranova O.I., Ramenskaya G.V., Gildeeva G.N., Shohin I.E.Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Том 118. 2018. С. 43-48
PHARMACOVIGILANCE SYSTEM IN EURASIAN ECONOMIC UNION ArticleAsetskaya I.L., Zyryanov S.K., Kolbin A.S., Belousov D.Yu.Качественная клиническая практика. 2018. С. 53-72
CLINICO-PHARMACOLOGICAL CHARACTERISTICS OF OPIOID DRUG-DRUG INTERACTIONS IN CANCER PATIENTS WITH CHRONIC PAIN SYNDROME ArticleBobrova O.P., Shnayder N.A., Zyryanov S.K., Dykhno Y.A., Petrova M.M., Nasyrova R.F.Siberian Journal of Oncology. Том 17. 2018. С. 114-122
ФАРМАКОЭКОНОМИЧЕСКОЕ ИССЛЕДОВАНИЕ ПРЕПАРАТОВ, ПРИМЕНЯЕМЫХ ПРИ ЛЕЧЕНИИ ПСОРИАЗА СРЕДНЕТЯЖЕЛОЙ И ТЯЖЕЛОЙ СТЕПЕНИ У ПАЦИЕНТОВ С НЕЭФФЕКТИВНОСТЬЮ БАЗОВОЙ СИСТЕМНОЙ ТЕРАПИИ ArticleЗырянов С.К., Белоусов Д.Ю., Чеберда А.Е.Клиническая фармакология и терапия. Том 27. 2018. С. 91-97
PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER ArticleFedyayev D.V., Zyryanov S.K.Medical Technologies. Assessment and Choice. 2018. С. 68-84
SELECTION OF MODERN P2Y12 INHIBITOR AS A PART OF DUAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON PRASUGREL ArticleZyryanov S.K., Baibulatova E.A.Лечебное дело. 2018. С. 50-61
PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS ArticleZyryanov S.K., Cheberda A.E., Belousov D.Y.Rational Pharmacotherapy in Cardiology. Том 14. 2018. С. 167-175
A PROBLEM OF INHALED DRUG SUBSTITUTIONS: AN ANALYSIS OF DATA FROM RUSSIAN DATABASE ON ADVERSE EVENTS ArticleZyryanov S.K., Zatolochina K.E., Asetskaya I.L.Pulmonologiya. Том 28. 2018. С. 424-429
THE MONITORING OF DRUG USE SAFETY IN THE MULTISPECIALITY HOSPITAL ArticleZyryanov S.K., Ivzhits M.A., Ivanov D.A.Хирург. 2018. С. 73-79
ВЗАИМОЗАМЕНЯЕМОСТЬ ПРЕПАРАТОВ - КЛИНИЧЕСКАЯ ЭФФЕКТИВНОСТЬ, БЕЗОПАСНОСТЬ ArticleЗырянов С.К., Фитилев С.Б., Шкребнева И.И., Возжаев А.В.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Том 9. 2017. С. 4-10
CLINICAL AND PHARMACOECONOMIC ASPECTS OF ANTI-TNF THERAPY CHANGE FOR MEDICAL REASONS ArticleGushchina U.S., Zyryanov S.K., Orlikhina I.A.Качественная клиническая практика. 2017. С. 35-42